Stream every public session from the 27th annual Global Conference right here on our website.

Watch Here
results for:

Content Type

Centers and Programs

Topics

Tags

Refine by Date

350
Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870 article
Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870
Submitted electronically Dr. Robert Califf Commissioner US Food and Drug Administration Silver Spri
ng, MD 20993 Dear Dr. Califf,
Jul 31, 2023
Venture Philanthropy in Action: A Case Study of EB Research Partnership and ProQR article
Venture Philanthropy in Action: A Case Study of EB Research Partnership and ProQR
.bubble-images, .bubble-images img { border-radius: 50%; } Venture Philanthropy in Action: A Case
Study of EB Research Partnership and ProQR How are nonprofit organizations leveraging venture philanthropy to ac
Jul 16, 2020
Milken Institute launches COVID-19 vaccine and treatment tracker article
Milken Institute launches COVID-19 vaccine and treatment tracker
Publicly available resource monitors the development of therapies to treat and prevent disease
Mar 18, 2020
Request for Information: Advancing Clinical and Translational Science through Accelerating the Decentralization of Clinical Trials, NIH RFI Notice Number NOT-TR-23-006 article
Request for Information: Advancing Clinical and Translational Science through Accelerating the Decentralization of Clinical Trials, NIH RFI Notice Number NOT-TR-23-006
Submitted electronically Joni Rutter, Ph.D. National Center for Advancing Translational Sciences Na
tional Institutes of Health 6701 Democracy Blvd Bethesda, MD 20892-4874 Dear Director Rutter,
May 12, 2023
Statement on the Zero-Draft Resolution of the “Scope, modalities, format and organization of the High Level Meeting on Antimicrobial Resistance convened by the President of the General Assembly” article
Statement on the Zero-Draft Resolution of the “Scope, modalities, format and organization of the High Level Meeting on Antimicrobial Resistance convened by the President of the General Assembly”
Submitted electronically 
Jan 18, 2024
TRAIN Newsletter — July 2024 article
TRAIN Newsletter — July 2024
TRAIN eNews is delivered directly to organizations that take part in The Research Acceleration and I
nnovation Network (TRAIN).
Jul 25, 2024
Comment Letter: Advanced Research Projects Agency for Health (ARPA-H) Request for Information article
Comment Letter: Advanced Research Projects Agency for Health (ARPA-H) Request for Information
Submitted electronically The Honorable Diana DeGette US House of Representatives Washington, DC 205
15 The Honorable Fred Upton US House of Representatives Washington, DC 20515
Jul 16, 2021
Request for Information on Improving Americans’ Access to Gene Therapies article
Request for Information on Improving Americans’ Access to Gene Therapies
Submitted electronically The Honorable Bill Cassidy, M.D. Ranking Member Committee on Health, Educa
tion, Labor & Pensions United States Senate Washington, DC 20510 Dear Ranking Member Cassidy,
Jan 22, 2024
Milken Institute COVID-19 tracker update identifies more than 100 vaccines and nearly 200 treatments in development article
Milken Institute COVID-19 tracker update identifies more than 100 vaccines and nearly 200 treatments in development
Nine vaccines and more than 50 treatment candidates currently in clinical trials.
May 4, 2020
Comment Letter: Food and Drug Administration (FDA) – Medical Device User Fee Act (MDUFA) article
Comment Letter: Food and Drug Administration (FDA) – Medical Device User Fee Act (MDUFA)
Dear Commissioner Hahn:
Nov 25, 2020
Letter of Support - Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act (PREVENT Pandemics Act) article
Letter of Support - Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act (PREVENT Pandemics Act)
Submitted electronically 
Aug 2, 2022
Milken Institute COVID-19 tracker update identifies dozens of new treatments and vaccines in development article
Milken Institute COVID-19 tracker update identifies dozens of new treatments and vaccines in development
Two potential vaccines moving to clinical trial stage in addition to WHO’s global SOLIDARITY trial
Mar 25, 2020